We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zika Vaccine Shows Promise For Treating Deadly Brain Cancer
Zika Vaccine Shows Promise For Treating Deadly Brain Cancer
News

A Zika vaccine candidate has shown promise as a treatment for the deadliest type of brain cancer.

Read more

Machine Learning Technique Predicts Human Cells' Organization
Machine Learning Technique Predicts Human Cells' Organization
News

Scientists have used machine learning to train computers to see parts of the cell the human eye cannot easily distinguish. Using 3D images of fluorescently labeled cells, the research team taught computers to find structures inside living cells without fluorescent labels, using only black and white images generated by an inexpensive technique known as brightfield microscopy.

Read more

Experimental Nasal Influenza Vaccine Tested in Kids, Teens
Experimental Nasal Influenza Vaccine Tested in Kids, Teens
News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

Read more

CRISPR Screen Identifies Gene That Helps Cells Resist West Nile, Zika Viruses
CRISPR Screen Identifies Gene That Helps Cells Resist West Nile, Zika Viruses
News

CRISPR used to identify a gene which helps cells resist a nasty class of pathogens.

Read more

Stuck on You - Targeting Bacterial Adhesion to Reduce Antibiotic Use
Stuck on You - Targeting Bacterial Adhesion to Reduce Antibiotic Use
News

Scientists have shown that cellulose serves a mortar-like role to enhance the adhesion of bacteria to bladder cells, causing urinary tract infections.

Read more

Gout Get Outta Here
Gout Get Outta Here
News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

Read more

 
 
 
Antimicrobial Resistance – the Rise of Global Superbugs
Antimicrobial Resistance – the Rise of Global Superbugs
Article

Antimicrobials have revolutionized medicine by enabling treatments for diseases that would once have proven fatal, however,they have since proven to be a double-edged sword.

Read more

Lytic vs Lysogenic – Understanding Bacteriophage Life Cycles
Lytic vs Lysogenic – Understanding Bacteriophage Life Cycles
Article

Bacteriophage (phage) are obligate intracellular viruses that specifically infect bacteria. Here we take an overview of their structure, life-cycle and the role they have played in advancing science and medicine.

Read more

Imaging in Biology: How Many Words are Cell Images Worth?
Imaging in Biology: How Many Words are Cell Images Worth?
Article

They say 'a picture is worth a thousand words.' Is this true for cell images?

Read more

The Essential Upgrade for Modern Pharmaceutical NMR: A Case Study
The Essential Upgrade for Modern Pharmaceutical NMR: A Case Study
Article

Against a background where analysts in the pharmaceutical industry are increasingly looking for accurate, easy-to-use and scalable methods, nuclear magnetic resonance spectroscopy has become established as a leading technique.

Read more

Why Pharma Is Rethinking Its Data Integration Strategy – the Criticality of Data Integration
Why Pharma Is Rethinking Its Data Integration Strategy – the Criticality of Data Integration
Article

The pharma industry is being disrupted in multiple ways. Data has never been more accessible and the speed at which it is flowing has left the industry reeling. Fundamental to the success of these advances is the need to integrate data from diverse sources and leverage predictive analytics to drive informed, real-time decisions. This article explores how pharma can maximize the value of different data types to advance research.

Read more

The Biosimilars Market is Likely to Grow at a Compound Annual Growth Rate of 49.1% from 2015 to 2020
The Biosimilars Market is Likely to Grow at a Compound Annual Growth Rate of 49.1% from 2015 to 2020
Article

The global biosimilars market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a compound annual growth rate (CAGR) of 49.1% during the forecast period 2015 to 2020, according to Allied Market Research’s report.

Read more